Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20141
20161
20171
20192
20201
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
United Therapeutics2
Aeris Therapeutics1
Bellus Health Inc. - a GSK company1
Eli Lilly and Company1
GlaxoSmithKline1
Grifols Therapeutics LLC1
Hoffmann-La Roche1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases11
Lung Diseases9
Bronchial Diseases3
Lung Diseases, Obstructive3
Pathologic Processes3
Pulmonary Disease, Chronic Obstructive3
Carcinoma, Bronchogenic2
Carcinoma, Non-Small-Cell Lung2
Cardiovascular Diseases2
Connective Tissue Diseases2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.